Spotlight
Clinical Role
Clinical
Supplement Spotlight
CME/CE
Subscribe
E. Thomas Carey, PharmD
Articles
Second Look at Utilization of a Closed-System Transfer Device (PhaSeal)
E. Thomas Carey, PharmD;Ryan A. Forrey, MS;Douglas Haughs, BS;Dawn Moore Jefferson, PharmD;James A. Jorgenson, RPh, MS;Derek M. McMichael, PharmD;John M. Mulvaney, MHA;Susan M. Spivey, Phar
December 11th 2011The Phaseal closed-system transfer device can extend the beyond-use date of pharmaceuticals, thereby reducing waste.
Read More
Utility of the PhaSeal Closed System Drug Transfer Device
Derek M. McMichael, PharmD;Dawn Moore Jefferson, PharmD;E. Thomas Carey, PharmD;Ryan A. Forrey, PharmD, MS;Susan M. Spivey, PharmD, DDS;John M. Mulvaney, MHA;James A. Jorgenson, RPh, MS;R.
February 2nd 2011The Phaseal closed system drug transfer device provides a mechanical barrier to the entry of contaminants into sterile solutions for up to 168 hours.
Read More
Latest Updated Articles
Published: June 11th 2024 | Updated: July 27th 2024
Balancing Trust and Technology: The Role of AI in Patient-Pharmacist Interactions
Published: June 11th 2024 | Updated: July 27th 2024
Addressing Disparities in AI-Driven Diagnostics: Ethical and Practical Implications
Published: July 23rd 2024 | Updated: July 27th 2024
VP Kamala Harris’s Policies and Stances on Health Care, Reproductive Rights Take Center Stage
Published: October 18th 2023 | Updated: July 27th 2024
Pharmacists Can Optimize Treatment for Patients with NASH, Decreasing Economic Burden
Published: July 23rd 2024 | Updated: July 27th 2024
Trivalent Influenza Vaccines Are Readied for Fall
Published: July 15th 2024 | Updated: July 27th 2024
Biosimilar Ranibizumab Could be More Cost-Effective Than Aflibercept for nAMD
